LAB Research To Host Safety Pharmacology Seminar In Madison, WI
August 13th, 2008 | by admin |LAB Research Inc. (”LRI” or “LAB Research”) (TSX: LRI), a rapidly growing global non-clinical contract research organization, announced that it will host an exhibitor’s seminar titled “Study Design in Safety Pharmacology: Emerging Trends in Drug Development” at the upcoming 2008 Safety Pharmacology Society Meeting in Madison, WI.
The informative seminar will take place on Tuesday, 23rd September from 7:00am - 8.00am. The session will be lead by Dr. Simon Authier of LAB Research as well as scientific leaders from AstraZeneca, GlaxoSmithKline and Johnson & Johnson. This seminar will provide the participants the opportunity to learn and evaluate the emerging trends in study design and their impact on different phases of drug development. This seminar draws on a broad range of global safety pharmacology experts who have introduced novel study designs and methodologies, which are important to the conduct of non-clinical safety pharmacology studies.
“Safety pharmacology continues to be a growing focus in the preclinical field, states Luc Mainville, President and CEO of LAB Research. It is a seminar that supports new state-of-the-art research methods. LAB Research contributes to such advances with educational seminars such as this one as well as our continued support to the Safety Pharmacology Society.”
Scientific Sessions will focus on:
- Current and future methods of conducting CV and respiratory studies in safety pharmacology
- Selection of the most appropriate models
- Emerging technologies and its impact on Safety Pharmacology endpoints
- Safety Pharmacology Investigations in Toxicology Studies: Added value or limitation?
Individuals interested in attending this free Safety Pharmacology seminar are encouraged to register online at http://www.labresearch.com/corporate-events.htm, or via e-mail at safetypharm@labresearch.com.
About Lab Research Inc.
LAB Research is a Canadian global non-clinical contract research organization that provides contract research services to the pharmaceutical, biotechnology, agro-chemical, petro-chemical and industrial markets. LAB Research supports the development of its customers’ products from three state-of-the-art facilities located in Canada, Denmark and Hungary. LAB Research’s shares trade on the TSX under the symbol “LRI”.
Lab Research Inc.
Stumble it!
